Vytorin Protects Chronic Kidney Disease Patients From Major Vascular Events
Experimental drug Vytorin (ezetimibe/simvastatin) was found to lower the risk of major vascular events by 16.1% compared to a placebo for patients with chronic kidney disease, Merck Co announced today. Vytorin is a cholesterol lowering medication. Examples of major vascular events are non-fatal heart attacks, stroke or any type of revascularization procedure. Ezetimibe/simvastatin is currently approved for patients with primary hypercholesterolemia or mixed hyperlipidemia... (Source: Health News from Medical News Today)
Dangerous Dust
What would you do if you found out that the roads you drive on could cause cancer? This is the reality that residents face in Dunn County, North Dakota. For roughly 30 years, gravel containing the potentially carcinogenic mineral erionite was spread on nearly 500 kilometers of roads, playgrounds, parking lots, and even flower beds throughout Dunn County... (Source: Health News from Medical News Today)
